|
Q1 FY2019
As of Mar 31, 2019
|
Q4 FY2018
As of Dec 31, 2018
|
Q3 FY2018
As of Sep 30, 2018
|
Q2 FY2018
As of Jun 30, 2018
|
Q1 FY2018
As of Mar 31, 2018
|
Q4 FY2017
As of Dec 31, 2017
|
Q3 FY2017
As of Sep 30, 2017
|
Q2 FY2017
As of Jun 30, 2017
|
Q1 FY2017
As of Mar 31, 2017
|
Q4 FY2016
As of Dec 31, 2016
|
Q3 FY2016
As of Sep 30, 2016
|
Q2 FY2016
As of Jun 30, 2016
|
Q1 FY2016
As of Mar 31, 2016
|
Q4 FY2015
As of Dec 31, 2015
|
Q3 FY2015
As of Sep 30, 2015
|
Q2 FY2015
As of Jun 30, 2015
|
Q1 FY2015
As of Mar 31, 2015
|
Q4 FY2014
As of Dec 31, 2014
|
Q3 FY2014
As of Sep 30, 2014
|
Q2 FY2014
As of Jun 30, 2014
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||||
| Real estate | ||||||||||||||||||||
| Land | ||||||||||||||||||||
| Land held for development | ||||||||||||||||||||
| Buildings and improvements, net | ||||||||||||||||||||
| Real estate under development | ||||||||||||||||||||
| Total real estate | ||||||||||||||||||||
| Cash and cash equivalents | ||||||||||||||||||||
| Restricted cash | ||||||||||||||||||||
| Accounts receivable, net | ||||||||||||||||||||
| Prepaid expenses and other assets | ||||||||||||||||||||
| Investments in unconsolidated entities | ||||||||||||||||||||
| Deferred financing fees, net | ||||||||||||||||||||
| Lease intangibles, net | ||||||||||||||||||||
| Other intangible assets, net | ||||||||||||||||||||
| Assets associated with real estate held for sale | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Liabilities and equity | ||||||||||||||||||||
| Liabilities | ||||||||||||||||||||
| Notes payable, net | ||||||||||||||||||||
| Accounts payable and accrued liabilities | ||||||||||||||||||||
| Payables to related parties | ||||||||||||||||||||
| Acquired below-market leases, net | ||||||||||||||||||||
| Distributions payable | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Obligations associated with real estate held for sale | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Series A Convertible Preferred Stock | ||||||||||||||||||||
| Equity | ||||||||||||||||||||
| Preferred stock, $.0001 par value per share; 17,500,000 shares authorized, none outstanding | ||||||||||||||||||||
| Convertible stock, $.0001 par value per share; 1,000 shares authorized, none outstanding | ||||||||||||||||||||
| Common stock, $.0001 par value per share; 382,499,000 shares authorized, 55,298,782 and 53,839,766 shares issued and outstanding at March 31, 2019, and December 31, 2018, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Cumulative distributions and net loss attributable to common stockholders | ||||||||||||||||||||
| Accumulated other comprehensive income (loss) | ||||||||||||||||||||
| Stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interests | ||||||||||||||||||||
| Total equity | ||||||||||||||||||||
| Total liabilities and equity | ||||||||||||||||||||
Loading...
